News

BioM's articles and press releases about the Bavarian biotechnology sector


Bruker has acquired Munich-based Dynamic Biosensors

Bruker Cor­por­a­tion strengthens its port­fo­lio with the ac­quis­i­tion of Mu­nich-based Dy­nam­ic Bi­o­sensors GmbH. The com­pany…

Kurma Partners raises EUR 140 million in the first closing of its Biofund IV

Paris and Mu­nich-based ven­ture cap­it­al­ist Kurma Part­ners has reached the first clos­ing of its Bio­fund IV with EUR 140 mil­lion.…

Helmholtz Munich: New approach to idiopathic pulmonary fibrosis

Re­search­ers from Helm­holtz Mu­nich in co­oper­a­tion with an in­ter­na­tion­al team have dis­covered a key mech­an­ism that con­trib­utes…

Antibody conjugate shows huge progress in breast cancer treatment

An in­ter­na­tion­al team of re­search­ers led by Prof. Nadia Harbe­ck has made a sig­ni­fic­ant ad­vance in breast can­cer treat­ment. The…

Anette-Gabriele Ziegler Awarded Prestigious Rachmiel Levine Medal

Prof. Anette-Gab­ri­ele Zie­g­ler, Dir­ect­or of the Helm­holtz Mu­nich In­sti­tute for Dia­betes Re­search, was awar­ded the 2024…

Formycon and Fresenius Kabi receive EU approval for FYB202/Otulfi® (ustekinumab) for the treatment of inflammatory diseases

For­my­con AG from Martin­sried near Mu­nich and its com­mer­cial­iz­a­tion part­ner Freseni­us Kabi have re­ceived ap­prov­al from the…

BIO-Europe Spring 2025: Secure Your Spot at the Bavarian Booth!

This March, BIO-Europe Spring re­turns for a dy­nam­ic in-per­son ex­per­i­ence, and BioM is ex­cited to in­vite you to join us! From 17 –…

Pentixapharm from Würzburg/Berlin sets price range for planned IPO

Pentixapharm Hold­ing AG, fo­cused on the de­vel­op­ment of first-in-class ra­dio­phar­ma­ceut­ic­als, has an­nounced the price range for…

Eisbach starts Phase 1/2 trial of EIS-12656 in advanced solid tumours: first patient treated

Eis­bach Bio GmbH, a privately held clin­ic­al-stage bi­o­tech­no­logy com­pany fo­cused on can­cer medi­cines lever­aging syn­thet­ic…

Spin-off with the m4 Award - 8th call now open

You are an aca­dem­ic re­search team in the field of bio­medi­cine and want to spin off? Then the m4 Award is the per­fect op­por­tun­ity…

Newsletter

Subscribe

Archive


14.10.2024

vfa bio Biotechnologie im Verband Forschender Arzneimittelhersteller e.V.

vfa fordert solide Fin­an­zier­ung der Kranken­kassen

14.10.2024

Friedrich-Alexander-Universität Erlangen-Nürnberg

Die Schup­pen­flechte im Vis­i­er

09.10.2024

vfa bio Biotechnologie im Verband Forschender Arzneimittelhersteller e.V.

Chemie-No­bel­pre­is 2024: Pharmaun­terneh­men nutzen Pro­tein­vorhersage und -design für neue Medika­mente

09.10.2024

vfa bio Biotechnologie im Verband Forschender Arzneimittelhersteller e.V.

Fach­kräfte­m­an­gel in der Phar­main­dus­trie – vfa und IGBCE fordern polit­ische Maß­nah­men


Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager